
|
Channels
|
||||
|
Medical Health Encyclopedia
Cervical Cancer - Diagnosis
From Healthscout's partner site on prostate, HealthCentral.com
(Page 4) These classifications are based on the 2001 Bethesda System (TBS), which is formulated to standardize the reporting of Pap test results: Atypical Squamous Cells. Atypical squamous cells (ASC) are mildly abnormal cells on the surface of the cervix. They may simply represent inflammation. Over 80% of these cells become normal, but unfortunately, 5 - 17% of these women have a chance for having cervical intraepithelial neoplasia (CIN) II and III dysplasia, which indicates potentially invasive cells. Atypical squamous cells are further categorized as:
![]() Among those with atypical squamous cells, immunosuppressed women and those with high-risk human papillomavirus infections are at higher risk for cervical intraepithelial neoplasia II and III and should always be given colposcopy. Postmenopausal women with normal immune systems have a lower risk than younger women. In general, the actual risk for cervical cancer in women with atypical squamous cells is only 0.1 - 0.2%. Squamous Intraepithelial Lesions (SILs). Squamous intraepithelial lesions (SILs) are classified as either low-grade (LGSIL) or high-grade (HGSIL). High-grade SILs are more serious than low-grade SILs, and need to be treated because they can develop into invasive cancer. Pap tests can identify the presence of SILs but not their grade. All patients with SILs should undergo colposcopy. A colposcopy can determine whether SILs are high-grade or low-grade and whether treatment is required. | ||||
|
Search
Health Tools
Featured Conditions
Resources
Find a Therapist
PR Newswire
|
New Features
|
|||
|
||||